Clearview Cancer Institute offers patients whose diseases, when appropriate, require a more intensive treatment. This involves using high doses of chemotherapy followed by autologous peripheral blood stem cell transplant.
The Clearview Cancer Institute of Huntsville, Alabama, has initiated a Peripheral Blood Stem Cell Transplantation (PBSCT) program to provide this treatment option to the patients of northern Alabama and south-central Tennessee. The transplant program at Oncology, PC, is one of the first 100 transplant programs in the United States to receive national accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT).
During this treatment, the patient donates his/her own cells (called stem cells) which grow important parts of the bone marrow and blood. When enough of these cells have been collected and stored in a special freezer, the patient receives very high doses of chemotherapy to kill all the cancer cells. This treatment improves survival for some patients with Multiple Myeloma, Non-Hodgkin’s lymphoma, Hodgkin’s Lymphoma, and certain leukemias.
Your oncologist will recommend this treatment if he or she feels it will benefit you.
If you have questions, you may contact the transplant office at (256) 705-4226.
NOTE: These links are to resources not affiliated with Clearview.